Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Cancer Research

Adoptive Immunotherapy With Engineered T Cells Expressing and HLA-A2 Restricted Affinity-Enhanced TCR for LAGE-1 and NY-ESO-1 in Patients With Multiple Myeloma Following Auto-SCT

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2013English

Durability of Responses in Patients With Metastatic Renal Cell Carcinoma Treated With High Dose Interleukin-2 (HD IL-2)

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2015English

Nuclear IRF-1 Expression as a Mechanism to Assess “Capability” to Express PD-L1 and Response to PD-1 Therapy in Metastatic Melanoma

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2017English

In Vivo Depletion of CD25+ Cells Prior to LRAST Increases Therapeutic Efficacy in a Murine Melanoma Model

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2014English

Longitudinal NK Cell Kinetics and Cytotoxicity in Children With Neuroblastoma Enrolled in a Clinical Phase II Trial

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2020English

Targeting of M2-Like Tumor-Associated Macrophages With a Melittin-Based Pro-Apoptotic Peptide

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2019English

Histone Deacetylase Inhibitors Valproic Acid and Vorinostat Enhance Trastuzumab-Mediated Antibody-Dependent Cell-Mediated Phagocytosis

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2020English

CART Cells Are Prone to Fas- And DR5-mediated Cell Death

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2018English

Correction To: Immunotherapy Utilizing the Combination of Natural Killer– And Antibody Dependent Cellular Cytotoxicity (ADCC)–Mediating Agents With Poly (ADP-ribose) Polymerase (PARP) Inhibition

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2019English

Intratumoral Immunotherapy With the TLR7/8 Agonist 3m-052

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy